FDA Drug Recalls

Recalls / Class II

Class IID-0488-2024

Product

Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ

Brand name
Timolol Maleate
Generic name
Timolol Maleate
Active ingredient
Timolol Maleate
Route
Ophthalmic
NDCs
64980-513, 64980-514
FDA application
ANDA077259
Affected lot / code info
Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.

Why it was recalled

Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.

Recalling firm

Firm
FDC Limited
Manufacturer
Rising Pharma Holdings, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
B-8 MIDC Industrial Area, Waluj District, Aurangabad, Maharashtra State, N/A N/A, India

Distribution

Quantity
382,104 units
Distribution pattern
New Jersey Only

Timeline

Recall initiated
2024-04-25
FDA classified
2024-05-07
Posted by FDA
2024-05-15
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0488-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Timolol Maleate · FDA Drug Recalls